Table 1 Cuticular hydrocarbons (CHCs) that showed significant intraspecific differences in accumulation due to having only a single allele within the region spanned by a deficiency (Df), i.e., due to being hemizygous

From: The genetic basis of female pheromone differences between Drosophila melanogaster and D. simulans

		CHC Name ^a	n -C21	n -C22	n -C23	n -C24	n -C25	n -C27	9-T	7-T	5-T	7-P	5-P	9-H	7-H	7-N	9,13-PD	7,11-PD	9,13-HD	7,11-HD	7,11-ND	23-Br	25-Br	26-Br	27-Br	29-Br	31-Br
		Carbons ^b	21	22	23	24	25	27	23	23	23	25	25	27	27	29	25	25	27	27	29	23	25	26	27	29	31
		Features ^b	–	–	–	–	–	–	1D	1D	1D	1D	1D	1D	1D	1D	2D	2D	2D	2D	2D	B	B	B	B	B	B
Df ^c	Cyto.^d	Genes ^e
Df(3L)ED4457 [1]	67E2;68A7	98																			***
Df(3L)ED4486 [2]	69E6;69F6	49											**		**
Df(3L)fz-GF3b	70C1;70D2	45							**					**											**
Df(3L)ED4782	75F2;76A1	22												****			**
Df(3L)XS533 [3]	76B4;77B	161		**			****						***											**
Df(3L)ri-79c	77B;77F3	120			***														*	***
Df(3L)BSC284 [4]	78F1;79A3	16	***											*						***
Df(3L)BSC223 [5]	79B2	8																***
Df(3L)BSC249	79B2	8										****					***
Df(3L)ED5017	80A4;80C2	23			***		**			****	***			***											**
Df(3R)ME15	81F3;82F4	101	****		****		***
Df(3R)3-4	82F5;82F7	15										**
	82F8;82F10	8																				**
Df(3R)ED5156	82F8;82F10	8																				*
	82F10;83A4	26						**						*
Df(3R)Exel6144	83A6;83B3	14															**
Df(3R)ED5177 [7]	83B6	5												*
Df(3R)p712	84D4;85A4	159		*
Df(3R)ED5330 [8]	85A5;85D1	83																			****
Df(3R)BSC38	85F1;86C1	69	**
Df(3R)M-Kx1	86C7;86D8	61						*
	86D9;87B5	139					****					****
Df(3R)T-32 [9]	86D9;87B5	139					****					**
	87B1;87C1	82		*	****	****								***						**						*
Df(3R)ED5644	88A4;88C9	77										****					***
Df(3R)ED5664	88D1;88E3	57								*		****
Df(3R)BSC471 [10[	88E3;88E5	9	***	*	***									***				****		**		***				**
Df(3R)P115	89B7;89E7	97															*						**
Df(3R)ED5780	89E11;89F4	31																			****
Df(3R)Cha7 [11]	91B1;91F1	71	***		****						*	***		***								*	***
	91F1;91F5	14		***		**
Df(3R)Dl-BX12 [12]	91F1;91F5	14		**		**
	91F6;92B3	63																									***
Df(3R)e-R1 [14]	93B6;93C5	31														**
Df(3R)e-GC3	93D3;94A4	119												**				**
Df(3R)BSC56	94E1;94E9, 94F1;94F2	30		**																		**
Df(3R)Exel9012 [15]	94E9;94E13	15												**
Df(3R)crb87-5	96A7	3		***
Df(3R)ED6220 [19]	96A18;96C3	94			***		***				***									*	**
Df(3R)Exel6203 [20]	96E2;96E6	9												*			*
Df(3R)BSC321	96E6;96E9	13	***								**	***									*
Df(3R)BSC140 [21]	96F1	2						*						***			***
Df(3R)3450	98E3;99A8	82										****		****			**
Df(3R)BSC547 [22]	99B5;99B6	5	**							***				***
Df(3R)L127	99C8;99E4	65																****				*
Df(3R)B81	99C8;99E4	65																***				***
	99E4;100E1	181					**	***
Df(3R)ED50003 [23]	100E1;100F5	6								***	***	*					**

^aCHC name abbreviations are shown; full names can be found in the legend of Fig. 2. The primary compounds that have historically been studied in this species pair have their name underlined
^bCHCs are ordered based on the number of carbons within the chain and whether the compound is a simple chain with no defining features (-), has one (1D) or two (2D) double bonds, or a branch in the carbon chain (B) with a 2-methyl group. Note that no lines were significant for compounds 6-T, 7,11-He + D, or n-C29, and so those columns are not shown
^cThe italicized number in brackets [#] next to the deficiency name is the same as that overlaid on the biochemical pathway in Fig. 4, and is shown to facilitate comparison. Numbering is based on compounds listed in Table 2, and thus in Table 1 not all deficiencies have a number and not all numbers are listed
^dThe cytological region (Cyto.) underlying the significant effect was determined through comparison among overlapping significant and/or non-significant deficiencies. Since cytological breakpoints are not precise for all deficiencies, in some cases we assumed that the significant region was at the margin where a significant and non-significant deficiency both ended. Note that some deficiencies are divided into multiple rows, where the region of overlap indicates that some compounds are affected by one region of the deficiency, while others are affected by a different region. CHCs that had a significant change due to hemizygosity for that region have their P-value represented by * ≤ 0.05, ** ≤ 0.005 *** ≤ 0.0005 **** ≤ 0.0001; all others were not statistically significant. Compounds that significantly increased in sim/Df have their P-value representation underlined; those that decreased are not underlined
^eThe number of protein-coding genes (Genes) within each region was determined using CytoSearch in FlyBase

Back to article page

Search

Quick links